A ground breaking study published in PLOS Medicine, describes a mouse model with a humanized liver used for detecting hepatic drug toxicity prior to human testing. If these TK-NOG mice were available to be used for preclinical testing in 1993, the tragedy of the FIAU human trial could have been avoided, in which 7 of 15 participants suffered liver failure with lactic acidosis and 5 subsequently died.



Fast-growing fields as toxicology research, demand a quickly available and customizable pool of antibodies to avoid needless bottlenecks in research. Custom antibodies offer a solution to the lack of readily available catalogue antibodies against new targets and keep you in the frontier of toxicology research.